ロード中...

Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions

Pancreatic cancer (PC) incidence rates are rapidly increasing in developed countries, with half the patients being metastatic at diagnosis. For decades, fluorouracil, then gemcitabine regimens were the preferred palliative first-line options for fit patients with metastatic PC. FOLFIRINOX (a combina...

詳細記述

保存先:
書誌詳細
出版年:Therap Adv Gastroenterol
主要な著者: Lambert, Aurélien, Gavoille, Céline, Conroy, Thierry
フォーマット: Artigo
言語:Inglês
出版事項: SAGE Publications 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557187/
https://ncbi.nlm.nih.gov/pubmed/28835777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X17713879
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!